# A Study To Evaluate The Effect Of Itraconazole On Pharmacokinetics Of PF-06463922 In Healthy Volunteers

> **NCT02838264** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06463922
- **DRUG:** PF-06463922
- **DRUG:** PF-06463922
- **DRUG:** PF-06463922
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT02838264
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-16
- **Primary completion:** 2017-03-31
- **Final completion:** 2017-05-03
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02838264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02838264, "A Study To Evaluate The Effect Of Itraconazole On Pharmacokinetics Of PF-06463922 In Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02838264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*